Abstract: 1-β-D-Arabinofuranosylcytosine (Ara-C), a cytidine analogue, inhibits DNA synthesis and is used for the treatment of myelogenous leukemia. On the other hand, it is also known that Ara-C has a teratogenic effect. In the present study, pregnant rats were treated with 250 mg/kg of Ara-C on day 13 of gestation, and fetal tissues and placentae were collected from 3 to 48 hours after treatment to examine the sequential histopathological changes induced by prenatal Ara-C treatment. The weights of fetuses and placentae and the thickness of the placental labyrinth zone were significantly reduced at 48 hours after treatment. In the fetal tissues such as central nervous system and mesenchymes and in the placental labyrinth zone, the number of pyknotic cells stained positively by the TUNEL method increased markedly after treatment with Ara-C. In most fetal tissues, the number began to increase from 3 to 6 hours and peaked at 9 to 12 hours after treatment. In the placental labyrinth zone, the number peaked at 6 hours after treatment. Electron microscopical features of the pyknotic cells consisted with the ultrastructural characteristics of apoptotic cells. In various fetal organs and placentae, abnormal induction of apoptosis is suggested to induce growth inhibition and have a certain relation to the malformations. Moreover, abnormal induction of apoptosis would have a deep connection with the cytotoxic effect of Ara-C which may affect proliferative cells in fetuses and placentae developing rapidly. (J Toxicol Pathol 2003; 16: 223-229) 
Introduction
1-β-D-Arabinofuranosylcytosine (Ara-C), a cytidine analogue, inhibits DNA synthesis and is cytotoxic to proliferating cells especially those in the DNA synthetic phase of the cell cycle 1 . Therefore, it has been used as one of the most effective agents in the clinical treatment of myelogenous leukemia 2 . On the other hand, prenatal treatment of Ara-C has a teratogenic effect in experimental animals causing malformations of the central nervous system (CNS), palate, limb, kidney, and tail of the offspring 3 -8 . Although increased death of actively proliferating cells in fetal tissues is suggested to be related with the teratogenicity of Ara-C, very few attempts have been made on the sequential examination of the Ara-Cinduced histopathological changes that may spread widely over the fetal tissues. Thus the mechanism of malformations observed in various parts of fetal body is not well known. It was reported that injection of Ara-C to pregnant mice induced increased apoptosis of neuroepithelial cells in the fetal telencephalon 9 and Ara-C caused apoptosis in many different cell culture models [10] [11] [12] . However, due to the lack of reports regarding fetal cell apoptosis induced by transplacental exposure of Ara-C, little is known about the mechanism of fetotoxic effect of Ara-C including its relationship with cytotoxicity, i.e. an increase in apoptosis of fetal cells, in vivo. Other teratogenic drugs such as 5-azacytidine and ethylnitrosourea also cause apoptosis in the fetal CNS by injection into pregnant rats and these agents were suggested to cause inhibition of fetal development through abnormal induction of apoptosis 13, 14 . These reports raise a possibility that developing placenta is affected by Ara-C treatment. Nevertheless, little attention has been given to the toxic effect of Ara-C on the placenta so far, though dysfunction of the placenta would not be irrelevant to abnormal development of fetuse 15 . In the present study, we examined the sequential histopathological changes in the wide extent of fetal tissues and placentae obtained from dams treated with Ara-C on day 13 of gestation (GD13) as the first step to clarifying the mechanisms of Ara-C-induced apoptosis and its relationship with the teratogenicity and fetotoxicity.
Materials and Methods

Animals and Chemicals
Pregnant Slc:Wistar rats (plug day: day 0 of gestation) were obtained from Japan SLC Inc., Shizuoka, Japan. They were kept under controlled conditions (temperature, 23 ± 2°C; relative humidity, 55 ± 5%) using an isolator caging system (Niki Shoji Co., Tokyo, Japan) and were fed commercial pellets (MF, Oriental Yeast Co., Tokyo, Japan) and water ad libitum. Ara-C (Sigma, St. Louis, MO, US) was dissolved in phosphate-buffered saline (PBS). The protocol of the present study has been approved by the Animal Care and Use Committee of Graduate School of Agricultural and Life Sciences, The University of Tokyo.
Treatments
Eighteen pregnant rats were injected intraperitoneally (i.p.) with 250 mg/kg of Ara-C on GD 13. At 3, 6, 9, 12, 24, and 48 hours (h) after injection, 3 dams were sacrificed by heart puncture under ether anesthesia, then fetuses and placentae were collected. As controls, 18 pregnant rats were injected i.p. with PBS in the same way and sacrificed at the same time point as Ara-C-treated groups. The weights of fetuses and placentae were measured at 48 h after treatment. The CNS of fetuses and placentae collected from dams at 6 h after treatment were examined ultrastructurally as mentioned below. The dose adopted in this study was decided based on the results of preliminary experiments, in which dams were not severely injured and almost all the fetuses and placentae were affected obviously.
Histopathology
The fetuses and placentae were fixed in 10% neutralbuffered formalin. Four-µm paraffin sections were stained with hematoxylin and eosin (HE) and the severity of histological changes were evaluated. Paraffine sections were also subjected to in situ detection of fragmented DNA as mentioned below. In addition, the thickness of the placental labyrinth zone close to the central portion was measured at 48 h after treatment. From a dam, two randomly chosen fetuses and placentae were examined.
Electron microscopy
Fetal brains and placentae were fixed in 2% glutaraldehyde in 0.1 M phosphate buffer (PB) and postfixed in 1% osmium tetroxide in the same buffer. After dehydration through an ascending ethanol series and propylene oxide, tissues were embedded in Epon 812 resin (Oken, Tokyo, Japan). Semithin sections were stained with toluidine blue for light microscopic survey. Urtrathin sections of selected areas were double-stained with uranyl acetate and lead citrate and observed under a JEOL 1200 EX electron microscope (Nippon Denshi, Tokyo, Japan).
Detection of fragmented DNA
Cells with fragmented DNA were detected by the terminal deoxynucleotidyltransferase-mediated dUTP end labelling (TUNEL) method, which was first proposed by Gavrieli et al. 16 and is now widely used for the detection of apoptotic cells, using an apoptosis detection kit (Apop Tag; Intergen, Purchase, NY, US). In brief, multiple fragmented DNA 3'-OH ends on the section were labeled with d i g o x i g e n i n -d U T P i n t h e p r e s e n c e o f t e r m i n a l deoxynucleotidyl transferase (TdT). Peroxidase-conjugated anti-digoxigenin antibody was then reacted with the sections. Apoptotic nuclei were visualized by peroxidasediaminobenzidine (DAB) reaction. The sections were then counterstained with methyl green.
Statistical analysis
The fetal and placental weights and the thickness of the placental labyrinth zone were expressed as mean ± standard deviation (SD) of 3 dams. Statistical analysis was carried out by the Student's t-test.
Results
The weights of the fetus and placenta were significantly reduced at 48 h after Ara-C treatment (Fig. 1a) . Histopathologically, Ara-C-treated fetuses are hypoplastic as a whole. In the placenta, reduction in the thickness of the labyrinth zone was prominent in the Ara-C-treated group (Fig. 1b) , and there were few significant histopathological differences in other parts of the placenta.
At 3 h after treatment, in the fetal tissues collected from pregnant rats treated with Ara-C, a slight increase in the number of pyknotic cells was observed in neuroepithelial cells of the CNS as well as in mesenchymal cells of the craniofacial tissue, limb bud and tail bud, and also hematopoietic progenitor cells of the liver. At 6 h after treatment, the number of pyknotic cells also began to increase in spinal ganglia, mesenchymal cells of the alimentary tract and lung, and germ cells of the gonads. In the CNS and craniofacial mesenchymes, the number peaked at 9 to 12 h after treatment (Fig. 2) . Almost similar peak time was also observed in other tissues. In the CNS, apoptosis was most frequently seen in the neuroepithelial cells in the outer side of the ventricular zone. After that, the number of pyknotic cells decreased towards 48 h after treatment, although the number was still somewhat higher than the control level (Table 1) .
In the placenta, trophoblastic cells showing pyknosis slightly increased in the labyrinth zone at 3 h after treatment. The number of pyknotic cells peaked at 6 h after treatment and decreased towards 48 h after treatment (Table 1 ). There were no marked increases in the pyknotic cells in other parts of the placenta including basal zone. Few pyknotic cells were observed in the fetal tissues and placentae from control dams throughout the experimental period.
Almost all of the nuclei of the pyknotic cells in the fetal tissues (Fig. 3) and placentae (Fig. 4) were positively stained by the TUNEL method. Electron microscopically, the pyknotic cells were characterized by shrinkage of the cell body, condensation of nuclear chromatin and/or margination of condensed chromatin along the nuclear membrane (Fig.  5) . Some nuclei were fragmented into small pieces, which were frequently ingested by adjacent cells (Fig. 6) .
Discussion
In the present study, the number of pyknotic cells in various fetal tissues and placenta increased markedly from several hours after treatment with Ara-C. Almost all of the nuclei of these pyknotic cells were stained positively by the TUNEL method which detects fragmented DNA in situ and is widely used for the evaluation of apoptotic cells. In addition, electron microscopical features of these cells consisted well with the ultrastructural characteristics of apoptotic cells. Therefore, it is reasonable to consider that these pyknotic cells are apoptotic ones. The significant reduction in the weights of the fetus and placenta suggests that the growth of these tissues were inhibited by the treatment with Ara-C and increased apoptosis may have a certain relation to this growth inhibition. Injection of Ara-C into pregnant rats brings about the malformations of the perinatal CNS such as microcephaly and hydrocephalus 4, 5 . Moreover abnormal cytoarchitecture in the cerebral cortex was reported in the murine offspring exposed to Ara-C transplacentally 17 . The present study suggests that abnormal increase in the number of apoptosis of neuroepithelial cells in the fetal CNS may be closely related to the impaired development of CNS.
In the CNS, apoptosis was most frequently seen in the neuroepithelial cells in the outer side of the ventricular zone. It was reported that the neuroepithelial cells in the outer side of the ventricular zone actively synthesized DNA 18 and that Ara-C exerted the cytotoxic effect through the inhibition of DNA synthesis when it was incorporated onto the end of growing DNA strand 1 . Thus, Ara-C seems to affect mainly the S phase cells even in fetuses growing rapidly and such cytotoxic effect would lead to apoptosis observed in various fetal organs. Further studies on the mechanisms of fetal cell apoptosis induced by transplacental exposure to Ara-C are now in progress.
In the rat CNS, abnormal induction of neuroepithelial cell apoptosis caused by prenatal treatment with other t e r a t o g e n i c d r u g s s u c h a s 5 -a z a c y t i d i n e 1 3 a n d ethylnitrosourea 14 was reported. The present study showed that Ara-C also caused a similar effect on the fetal CNS. These findings suggest that the fetal CNS might be highly sensitive to such genotoxic stimuli and easily cause apoptosis. On the other hand, the time of initiation and/or termination of apoptosis caused by these agents differed from each other and such difference in the time course of apoptotic response may reflect the differences in pharmacokinetics, metabolic activation, and signaling pathways involved in apoptosis among chemicals.
In addition to the CNS, abnormal increase in the apoptotic cell death was detected in craniofacial tissue, limb bud, and tail bud in the present study. These tissues well correspond to those in which anomalies are frequently reported in the offspring from dams administered with Ara-C 3, 4, 6 . Together with the results of CNS mentioned above, this strongly suggests that excess cell death through apoptosis may bring about lack of cell population required for the later normal histogenesis and organogenesis, resulting in anomalies.
In the placental labyrinth zone, the number of apoptotic cells which were stained positively by the TUNEL method began to increase from 3 h and peaked at 6 h after treatment. The significant reduction in the thickness of the placental labyrinth zone at 48 h after Ara-C treatment clearly indicates the inhibition of placental growth. Increased placental apoptosis was detected in human intra-uterine growth restriction 15 . Thus, at least a part of Ara-C-induced fetotoxity and teratogenicity may be secondary to the placental damage. However, it is reasonable to consider that the direct effect of Ara-C to fetuses is rather important in inducing such fetal toxicities because Ara-C distributes quickly into total-body fluid of maternal organs including fetuses 19, 20 . In addition, apoptosis was induced immediately after Ara-C treatment in both placenta and fetal tissues in the present study. We showed that the incidence of placental apoptosis was almost restricted to the labyrinth zone. As to other teratogenic reagents, 5-azacytidine causes atrophy of the placental labyrinth zone 21 and ethylnitrosourea causes increased induction of apoptosis in the same part of the placenta 22 . Trophoblastic cells in the placental labyrinth zone actively proliferate and synthesize DNA 23 . The proliferating activity can be connected with restricted distribution of placental changes induced by these agents. Additionally, apoptosis caused by lipopolysaccharides 24 and glucocorticoids 25 was also reported in rodent's placentae, but the distribution of the lesions was specific to drugs. The placenta is thought to be susceptible to endocrinological abnormality, inflammatory cytokine, and oxidative stress, and to result in the development of apoptosis. Also, in the present study, we demonstrated that placenta was susceptible to genotoxic stress and develops apoptosis.
The results of the present study may provide a clue for investigating the mechanisms of Ara-C induced apoptosis and the relationship with teratogenicity and fetotoxicity.
